Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair

Name: Work Video:
Duration: 3 min 30 s
Kunzah Jamal; Anna D. Staniszewska; Jacob Gordon; Shenghua Wen; Frank P. McGrath; Gregory Dowdell; Dominic Kabbabe; Giuditta illuzzi; Matthew Griffin; Barry R. Davies; Petra Hamerlik
{'id': 'https://openalex.org/W4282982199', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-2609', 'title': 'Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair', 'display_name': 'Abstract 2609: AZD9574 is a novel, brain penetrant PARP-1 selective inhibitor with activity in an orthotopic, intracranial xenograft model with aberrant DNA repair', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282982199', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-2609'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-2609', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5034773596', 'display_name': 'Kunzah Jamal', 'orcid': 'https://orcid.org/0000-0003-1063-4288'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Kunzah Jamal', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011515348', 'display_name': 'Anna D. Staniszewska', 'orcid': 'https://orcid.org/0000-0003-1328-1959'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Anna Staniszewska', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009947229', 'display_name': 'Jacob Gordon', 'orcid': 'https://orcid.org/0009-0006-8873-8481'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Jacob Gordon', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030967968', 'display_name': 'Shenghua Wen', 'orcid': 'https://orcid.org/0000-0003-4841-0917'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Shenghua Wen', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111495875', 'display_name': 'Frank P. McGrath', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Frank McGrath', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023791825', 'display_name': 'Gregory Dowdell', 'orcid': 'https://orcid.org/0009-0006-0879-3908'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Gregory Dowdell', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087315184', 'display_name': 'Dominic Kabbabe', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Dominic Kabbabe', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5004630297', 'display_name': 'Giuditta illuzzi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Giuditta illuzzi', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110293533', 'display_name': 'Matthew Griffin', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Matthew Griffin', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000275517', 'display_name': 'Barry R. Davies', 'orcid': 'https://orcid.org/0000-0002-5414-9113'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Barry R. Davies', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5006614002', 'display_name': 'Petra Hamerlik', 'orcid': 'https://orcid.org/0000-0002-5856-0161'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Petra Hamerlik', 'raw_affiliation_strings': ['1AstraZeneca UK, Cambridge, United Kingdom.'], 'affiliations': [{'raw_affiliation_string': '1AstraZeneca UK, Cambridge, United Kingdom.', 'institution_ids': ['https://openalex.org/I105036370']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.401, 'has_fulltext': False, 'cited_by_count': 13, 'citation_normalized_percentile': {'value': 0.999961, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '2609', 'last_page': '2609'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9346, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/parp1', 'display_name': 'PARP1', 'score': 0.93198586}, {'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.7130462}, {'id': 'https://openalex.org/keywords/ku80', 'display_name': 'Ku80', 'score': 0.47523096}], 'concepts': [{'id': 'https://openalex.org/C2778480876', 'wikidata': 'https://www.wikidata.org/wiki/Q21112674', 'display_name': 'PARP1', 'level': 5, 'score': 0.93198586}, {'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.7399245}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.7130462}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.6826018}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.6586386}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.6053535}, {'id': 'https://openalex.org/C102744134', 'wikidata': 'https://www.wikidata.org/wiki/Q22280388', 'display_name': 'Homologous recombination', 'level': 3, 'score': 0.59305334}, {'id': 'https://openalex.org/C178169997', 'wikidata': 'https://www.wikidata.org/wiki/Q2892636', 'display_name': 'Genome instability', 'level': 4, 'score': 0.5334048}, {'id': 'https://openalex.org/C187206112', 'wikidata': 'https://www.wikidata.org/wiki/Q3113091', 'display_name': 'Base excision repair', 'level': 4, 'score': 0.4974256}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.4773355}, {'id': 'https://openalex.org/C193104389', 'wikidata': 'https://www.wikidata.org/wiki/Q18032397', 'display_name': 'Ku80', 'level': 5, 'score': 0.47523096}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.46443376}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.44498682}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.31411403}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.28693396}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.23141688}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.21235645}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.14722595}, {'id': 'https://openalex.org/C94966510', 'wikidata': 'https://www.wikidata.org/wiki/Q2252764', 'display_name': 'DNA-binding protein', 'level': 4, 'score': 0.10154039}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-2609', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.64, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4388007145', 'https://openalex.org/W4387382776', 'https://openalex.org/W4236401480', 'https://openalex.org/W4206015794', 'https://openalex.org/W3135348276', 'https://openalex.org/W2888002479', 'https://openalex.org/W2604684522', 'https://openalex.org/W2548423821', 'https://openalex.org/W2031051286', 'https://openalex.org/W1645329610'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 81], 'Poly': [2], '(ADP-ribose)': [3], 'polymerase': [4], '(PARP)': [5], 'family': [6, 203], 'has': [7, 409], 'numerous': [8], 'essential': [9, 155], 'functions': [10], 'in': [11, 36, 94, 110, 126, 165, 209, 218, 238, 262, 285, 292, 310, 351, 378, 450], 'cellular': [12], 'processes': [13], 'such': [14], 'as': [15, 24, 26, 397], 'transcription,': [16], 'chromatin': [17], 'remodelling,': [18], 'DNA': [19, 41, 52, 60, 130, 458], 'damage': [20, 53], 'response': [21], 'and': [22, 34, 105, 114, 134, 151, 162, 180, 197, 207, 246, 255], 'repair': [23, 33, 74, 128, 459], 'well': [25], 'apoptosis.': [27], 'PARP': [28, 202], 'inhibition': [29, 143], 'blocks': [30], 'base': [31], 'excision': [32], 'results': [35], 'conversion': [37], 'of': [38, 51, 84, 91, 102, 129, 159, 186, 200, 224, 289, 320, 338, 349, 354, 359, 368, 383, 395, 463], 'SSBs': [39], 'to': [40, 146, 195, 271, 280, 298, 345, 411], 'double-strand': [42, 131], 'break': [43], '(DSBs).': [44], 'DSBs': [45, 67], 'are': [46, 116], 'the': [47, 89, 100, 127, 141, 157, 184, 201, 225, 263, 286, 299, 347, 352, 393, 412, 464], 'most': [48], 'deleterious': [49], 'form': [50], 'that': [54, 152, 175, 328, 389], 'can': [55, 68], 'be': [56, 69], 'generated': [57], 'by': [58, 71, 88, 177, 295, 324], 'exogenous': [59], 'damaging': [61], 'agents': [62], 'or': [63, 76], 'endogenous': [64], 'replication': [65, 135], 'stress.': [66], 'repaired': [70], 'homologous': [72], 'recombination': [73], '(HRR)': [75], 'non-homologous': [77], 'end': [78], 'joining': [79], '(NHEJ).': [80], 'physiological': [82], 'importance': [83], 'HRR': [85, 111, 226], 'is': [86, 123, 144, 154, 168, 440], 'underscored': [87], 'observation': [90], 'genomic': [92], 'instability': [93], 'HRR-deficient': [95], '(HRD+)': [96], 'cells': [97, 164, 266], 'and,': [98], 'importantly,': [99], 'association': [101], 'cancer': [103, 340, 406], 'predisposition': [104], 'developmental': [106], 'defects': [107], 'with': [108, 361, 403, 448, 456], 'mutations': [109], 'genes.': [112], 'PARP1': [113, 122, 142, 173, 182, 193, 215], 'PARP2': [115, 153, 196], 'required': [117], 'for': [118, 156, 192, 401, 467], 'SSB': [119], 'repair,': [120], 'while': [121], 'also': [124], 'involved': [125], 'breaks': [132], '(DSBs)': [133], 'fork': [136], 'damage.': [137], 'Recent': [138], 'reports': [139], 'suggest': [140], 'sufficient': [145], 'elicit': [147], 'an': [148, 451], 'anti-proliferative': [149], 'effect': [150], 'survival': [158, 382], 'hematopoietic': [160], 'stem': [161], 'progenitor': [163], 'animal': [166], 'models.AZD9574': [167], 'a': [169, 281, 311, 366, 379, 398, 441], 'novel': [170], 'brain': [171, 341, 443], 'penetrant': [172, 444], 'inhibitor': [174, 447], 'acts': [176], 'selectively': [178], 'inhibiting': [179], 'trapping': [181], 'at': [183], 'sites': [185], 'SSBs.': [187], 'AZD9574': [188, 213, 260, 290, 306, 321, 350, 371, 396, 439], 'exhibited': [189], '&amp;gt;8000-fold': [190], 'selectivity': [191, 247], 'compared': [194, 270, 297], 'other': [198], 'members': [199], '(PARP2,': [204], 'PARP3,': [205], 'PARP5a': [206], 'PARP6)': [208], 'biochemical': [210], 'assays.': [211], 'While': [212], 'inhibited': [214], 'enzymatic': [216], 'activity': [217, 449], 'all': [219], 'tested': [220], 'cell': [221, 240], 'lines': [222, 241], 'irrespective': [223], 'status': [227], '(IC50': [228], 'range': [229], 'between': [230], '0.3': [231], '-': [232], '2': [233], 'nM),': [234], 'colony': [235], 'formation': [236], 'assay': [237], 'isogenic': [239], 'pairs': [242], 'confirmed': [243], 'higher': [244], 'potency': [245], 'towards': [248], 'HRD+': [249, 404], 'models': [250], '(DLD1': [251], 'BRCA2-/-;': [252], 'SKOV-3': [253, 256], 'BRCA2-/-': [254, 264], 'PALB2-/-).': [257], 'For': [258], 'example,': [259], 'IC50': [261, 272, 291], 'DLD1': [265], 'was': [267, 343], '1.38': [268], 'nM': [269], '&amp;gt;': [273], '40': [274], 'µM': [275], 'BRCA2wt': [276, 293], 'cells,': [277], 'which': [278], 'corresponds': [279], '~20,000-fold': [282], 'greater': [283], 'efficacy': [284, 309, 348], 'BRCA2-/-cells': [287], '(ratio': [288], 'divided': [294], 'BRCA2-/-)': [296], 'wild': [300], 'type': [301], 'parental': [302], 'line.': [303], 'In': [304], 'vivo,': [305], 'demonstrated': [307], 'dose-dependent': [308], 'BRCA1': [312], 'mutant': [313], 'MDA-MB-436': [314], 'subcutaneous': [315], 'xenograft': [316, 336, 454], 'model.': [317], 'Anti-tumour': [318], 'effects': [319], 'were': [322, 329], 'manifested': [323], 'pronounced': [325], 'growth': [326, 375], 'regressions': [327], 'durable': [330], 'after': [331], 'treatment': [332], 'withdrawal.': [333], 'An': [334], 'intracranial': [335, 363, 453], 'model': [337, 455], 'breast': [339, 405], 'metastases': [342], 'developed': [344], 'assess': [346], 'context': [353], 'blood-brain': [355], 'barrier': [356], 'penetrance.': [357], 'Treatment': [358], 'animals': [360], 'established': [362], 'lesions': [364], 'using': [365], 'dose': [367], '3': [369], 'mg/kg': [370], 'showed': [372], 'sustained': [373], 'tumour': [374], 'suppression': [376], 'resulting': [377], 'significantly': [380], 'extended': [381], 'tumour-bearing': [384], 'mice.': [385], 'Collectively,': [386], 'we': [387], 'believe': [388], 'our': [390], 'data': [391], 'support': [392], 'development': [394], 'potential': [399], 'therapy': [400], 'patients': [402], 'whose': [407], 'disease': [408], 'spread': [410], 'brain.': [413], 'Citation': [414], 'Format:': [415], 'Kunzah': [416], 'Jamal,': [417], 'Anna': [418], 'Staniszewska,': [419], 'Jacob': [420], 'Gordon,': [421], 'Shenghua': [422], 'Wen,': [423], 'Frank': [424], 'McGrath,': [425], 'Gregory': [426], 'Dowdell,': [427], 'Dominic': [428], 'Kabbabe,': [429], 'Giuditta': [430], 'illuzzi,': [431], 'Matthew': [432], 'Griffin,': [433], 'Barry': [434], 'R.': [435], 'Davies,': [436], 'Petra': [437], 'Hamerlik.': [438], 'novel,': [442], 'PARP-1': [445], 'selective': [446], 'orthotopic,': [452], 'aberrant': [457], '[abstract].': [460], 'In:': [461], 'Proceedings': [462], 'American': [465], 'Association': [466], 'Cancer': [468, 479], 'Research': [469], 'Annual': [470], 'Meeting': [471], '2022;': [472], '2022': [473], 'Apr': [474], '8-13.': [475], 'Philadelphia': [476], '(PA):': [477], 'AACR;': [478], 'Res': [480], '2022;82(12_Suppl):Abstract': [481], 'nr': [482], '2609.': [483]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282982199', 'counts_by_year': [{'year': 2024, 'cited_by_count': 7}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 1}], 'updated_date': '2024-12-15T14:48:41.633828', 'created_date': '2022-06-17'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
